NewLink Genetics Announces Promising Clinical Data at ECC 2015
September 27, 2015 at 12:33 PM EDT
NewLink Genetics Corporation(NASDAQ: NLNK) announced promising early-stage clinical data from a phase 1a study of GDC-0919, an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.